Dubai, United Arab Emirates, January 19, 2022 (GLOBE NEWSWIRE) – World sales Bioimpedance Devices Market set to higher 492.1 million US dollars In 2022. We are expanding healthily 6.4% compound annual growth rate, the total market size is expected to reach 715.1 million USD by 2028.
Increased incidence of CKD is expected to contribute to the growth of CKD Bioimpedance Devices Market Throughout the forecast period. Chronic kidney disease (CKD) is a medical condition that can be characterized by the progressive loss of kidney function over time. According to the National Kidney Foundation, 30 million American adults have chronic kidney disease and millions more are at risk of developing chronic kidney disease.
|Estimated Bioimpedance Devices Market Size 2022||492.1 million US dollars|
|Compound annual growth rate (CAGR) based on Bioimpedance Devices market value (2022-2028)||~ 6.4%|
|Bioimpedance Devices Market Size Forecast in 2028||715.1 million USD|
Request a sample report to get comprehensive insights into https://www.futuremarketinsights.com/reports/sample/rep-gb-5563
Glomerular filtration rate (GFR) is the best overall indicator for studying kidney function. Bioelectrical impedance or Bioimpedance is used to improve the estimation of GFR in non-diabetic patients with CKD and also to estimate muscle mass. Bioelectrical impedance analysis (BIA) can also be used to measure hyperbolic lean mass (ALM).
The performance of these equations incorporating ALM BIA to estimate renal insulin clearance (GFR INU) can be compared with demographic variables and also used to make adjustments in diet for the treatment of renal disease (MDRD).
Diffuse online marketing channels have greatly increased the sale of Bioimpedance as well as handheld devices in recent years. For Instance, a research study estimated that in 2015, nearly 70% of the US population relied on online shopping portals to purchase various items.
The vendors operating in the Bioimpedance Devices market focus on promotional and online marketing strategies to ensure better access to their devices and increase sales. The devices offered online also help sellers reduce operating and distribution costs.
The online marketing channel also allows sellers to provide information about the devices in their portfolio and access global and local markets. In addition, these online marketing sites offer a wide range of high quality Bioimpedance systems at reasonable costs.
For any inquiries related to the report, ask @analyst https://www.futuremarketinsights.com/ask-question/rep-gb-5563
|Historical data available for||2022-2028|
|market analysis||Units of volume and million dollars of value|
|Main areas covered||North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan, Middle East and Africa.|
|Main countries covered||United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, North, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, other countries .|
|Main Market Segments Covered||Product type, method, users and region|
|An overview of the main companies||• General Electric Company
• Omron Corporation
• Fresenius Medical Care
• ImpediMed Ltd.
• JUNGLES AI Inc.
• Tanita Company
• RJL Systems, Inc.
• Maltron International Ltd.
• PODESTAT LIMITED
• SMT Medical GmbH
The majority of manufacturers in Bioimpedance Devices makers focus on developing affordable, portable products. Bioimpedance portable devices are becoming increasingly popular due to their various advantages. For example, Bioimpedance devices are non-invasive, reasonable, safe and easy to operate.
These devices are lightweight and therefore widely used in home healthcare settings to monitor the health of the whole family. All these factors are expected, cumulatively, to increase the demand for Bioimpedance Portable Devices during the forecast period. Bioimpedance portable/portable devices are also highly chosen by people for travel purposes.
For example, ImpediMed SFB7, a handheld Bioimpedance device, is in high demand, as this device is easy to carry. Technological developments to improve the quality of Bioimpedance devices and increase patient compliance are also expected to drive market growth during the forecast period.
Multi-frequency bio-impedance devices are highly preferred because these devices can measure impedances at different frequencies. This provides a better and more efficient estimation of lean mass, total body water, and intrinsic and extrinsic cellular water.
We provide tailor-made solutions to suit your requirements, customization request @ https://www.futuremarketinsights.com/customization-available/rep-gb-5563
Single-frequency Bioimpedance devices can calculate fat-free mass and total body water but these devices are not able to estimate body water both inside and outside the cell. The increasing popularity and growing awareness of Bioimpedance Multi-Frequency Devices is expected to boost the market growth of Bioimpedance Devices during the forecast period.
FMI has segmented the global Bioimpedance Devices market by product type, method and end user. The Bioimpedance Devices market is segmented, by product type, into single-frequency Bioimpedance devices and Multi-frequency Bioimpedance devices. By method, the Bioimpedance Devices market is segmented into Wired Bioimpedance Devices and Wireless Bioimpedance Devices.
Bioimpedance devices, by end users, are divided into hospitals, specialty clinics, rehabilitation centers and more. Segmentation by region includes North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan, and the Middle East and Africa. The Bioimpedance Wired Devices segment of the Bioimpedance Devices market is expected to witness significant growth during the forecast period.
The report tracks some of the major companies operating in the Bioimpedance Devices market, including General Electric Corporation, Omron Corporation, Fresenius Medical Care, Impedimide Limited, SELVAS AI Inc. , Tanita Corporation, RJL Systems, Inc. , Maltron International Ltd. , Bodystat Ltd and SMT Medical GmbH.
Buy [email protected] https://www.futuremarketinsights.com/checkout/5563
Discover comprehensive and ongoing FMI healthcare coverage
EMG Biosensors Market – According to the latest research by Fact.MR, the EMG biosensors market is set to witness steady growth during the year 2021-2031.
Interchangeable Biosimilars Market – According to the latest research by Future Market Insights, the interchangeable biosimilars market is set to experience 6% growth during the year 2021-2031.
Bio-Identical Hormone Therapy Market – According to the latest research by Future Market Insights, the bio-combined hormone therapy market is expected to grow at a compound annual growth rate of 5.2% during the forecast period.
Bioprocess containers and fluid transportation solutions market – According to the latest research by Future Market Insights, the bioprocess containers and fluid transportation solutions market is set to witness a growth of 14.7% during the year 2021-2031.
Topical Biochemicals Market – According to the latest research by Future Market Insights, the topical biochemicals market is set to experience growth during 2021-2031. The demand for topical adhesives is increasing due to the wide applications in various sectors of industries.
Airlift Bioreactor Market – According to the latest research by Future Market Insights, the airlift bioreactor market is set to experience positive growth at a compound annual growth rate of 11% during 2021-2031.
Bioimpedance Spectroscopy Market – According to the latest research by Future Market Insights, the Bioimpedance Spectroscopy market is set to witness a growth of 9.3% during the year 2021-2031.
Subcutaneous Biopharmaceutical Market – Pharmaceuticals are all pharmaceutical products developed using a biological process. Biological products include medicines manufactured from different organisms with the help of biotechnology.
Biosynthetic Renal Assistive Devices Market – The Biosynthetic Renal Assistive Devices Market study provides a comprehensive analysis of business models, key strategies, and market shares of some of the leading players in this landscape.
Swing Bioreactor Market – A bioreactor is a device in which a biological reaction is carried out using culture. This vital process using a bioreactor assists in the growth of cells or tissues.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in more than 150 countries. FMI is headquartered in Dubai, with delivery hubs in the UK, US and India. The latest market research and industry analysis reports from FMI help companies face challenges and make critical decisions with confidence and clarity amidst intense competition. Our customized and syndicated market research reports provide actionable insights that drive sustainable growth. FMI’s expert-led team of analysts constantly track emerging trends and events in a wide range of industries to ensure our clients are prepared for the evolving needs of their clients.
future market insights,
1602-6 Jumeirah Bay Tower X2,
Part Number: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
The United Arab Emirates
For sales inquiries: [email protected]
For media inquiries: [email protected]
Press release source: https://www.futuremarketinsights.com/press-release/bioimpedance-device-market